Sanofi

News

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

Sanofi to pay back Philippines after Dengue vaccine problems

Sanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, after serious safety concerns halted its use.

News

Lilly to research real world diabetes with digital health fi...

Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.

News

Sanofi's Dengue vaccine launch turns into nightmare

Philippines halts vaccination programme on safety issues

Sanofi turns the tables on Lilly with biosimilar fast-acting...

Big-selling Humalog facing cut price competition

News

Dance Biopharm to develop inhaled insulin with Phillips-Medi...

Biotech working on soft mist insulin delivery device with IT firm

News

Sanofi looks to Dupixent as diabetes sales plummet

Dupixent off to strong start after US launch

Sanofi to pay back Philippines after Dengue vaccine problems

Lilly to research real world diabetes with digital health fi...

Sanofi's Dengue vaccine launch turns into nightmare

Sanofi turns the tables on Lilly with biosimilar fast-acting...

Dance Biopharm to develop inhaled insulin with Phillips-Medi...

Sanofi looks to Dupixent as diabetes sales plummet

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks